BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32681675)

  • 1. Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium.
    Saberi B; Naik H; Overbey JR; Erwin AL; Anderson KE; Bissell DM; Bonkovsky HL; Phillips JD; Wang B; K Singal A; M McGuire B; Desnick RJ; Balwani M
    Hepatology; 2021 May; 73(5):1736-1746. PubMed ID: 32681675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Wang B; Bonkovsky HL; Lim JK; Balwani M
    Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword.
    Peoc'h K; Manceau H; Karim Z; Wahlin S; Gouya L; Puy H; Deybach JC
    Mol Genet Metab; 2019 Nov; 128(3):236-241. PubMed ID: 30413387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
    Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
    J Intern Med; 2022 Jun; 291(6):824-836. PubMed ID: 35112415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
    Horie Y; Yasuoka Y; Adachi T
    Orphanet J Rare Dis; 2023 Dec; 18(1):384. PubMed ID: 38066651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of inherited porphyrias in Europe.
    Elder G; Harper P; Badminton M; Sandberg S; Deybach JC
    J Inherit Metab Dis; 2013 Sep; 36(5):849-57. PubMed ID: 23114748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors.
    Andant C; Puy H; Bogard C; Faivre J; Soulé JC; Nordmann Y; Deybach JC
    J Hepatol; 2000 Jun; 32(6):933-9. PubMed ID: 10898313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hepatic porphyria and cancer risk: a nationwide cohort study.
    Baravelli CM; Sandberg S; Aarsand AK; Nilsen RM; Tollånes MC
    J Intern Med; 2017 Sep; 282(3):229-240. PubMed ID: 28730628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria.
    Sardh E; Wahlin S; Björnstedt M; Harper P; Andersson DE
    J Inherit Metab Dis; 2013 Nov; 36(6):1063-71. PubMed ID: 23344888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts.
    Wheeden K; Lyon Howe D; Burrell S; Gill L; Chamberlayne J; Williams ER; Simon A; Ko JJ; Mora J; Wells T; Evans C; Paulich M; Meninger S; Lombardelli S
    Adv Ther; 2022 Sep; 39(9):4330-4345. PubMed ID: 35907153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of association between hepatocellular carcinoma and porphyria variegata.
    Germanaud J; Luthier F; Causse X; Kerdraon R; Grossetti D; Gargot D; Nordmann Y
    Scand J Gastroenterol; 1994 Jul; 29(7):671-2. PubMed ID: 7939407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hepatic porphyrias and primary liver cancer.
    Andant C; Puy H; Faivre J; Deybach JC
    N Engl J Med; 1998 Jun; 338(25):1853-4. PubMed ID: 9634374
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
    Lissing M; Vassiliou D; Floderus Y; Harper P; Yan J; Hagström H; Sardh E; Wahlin S
    J Inherit Metab Dis; 2023 Mar; 46(2):286-299. PubMed ID: 36546345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute hepatic porphyrias: current status and future challenges.
    Siegesmund M; van Tuyll van Serooskerken AM; Poblete-Gutiérrez P; Frank J
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):593-605. PubMed ID: 20955962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias.
    Schneider-Yin X; van Tuyll van Serooskerken AM; Siegesmund M; Went P; Barman-Aksözen J; Bladergroen RS; Komminoth P; Cloots RH; Winnepenninckx VJ; zur Hausen A; Weber M; Driessen A; Poblete-Gutiérrez P; Bauer P; Schroeder C; van Geel M; Minder EI; Frank J
    J Hepatol; 2015 Mar; 62(3):734-8. PubMed ID: 25445397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
    Cohen AM; Chamberlin S; Deloughery T; Nguyen M; Bedrick S; Meninger S; Ko JJ; Amin JJ; Wei AJ; Hersh W
    PLoS One; 2020; 15(7):e0235574. PubMed ID: 32614911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of hepatocellular carcinoma in a case of hereditary coproporphyria.
    Andant C; Puy H; Deybach JC; Soulé JC; Nordmann Y
    Am J Gastroenterol; 1997 Aug; 92(8):1389-90. PubMed ID: 9260820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.
    Mariño Z; Darnell A; Lens S; Sapena V; Díaz A; Belmonte E; Perelló C; Calleja JL; Varela M; Rodriguez M; Rodriguez de Lope C; Llerena S; Torras X; Gallego A; Sala M; Morillas RM; Minguez B; Llaneras J; Coll S; Carrion JA; Iñarrairaegui M; Sangro B; Vilana R; Sole M; Ayuso C; Ríos J; Forns X; Bruix J; Reig M
    J Hepatol; 2019 May; 70(5):874-884. PubMed ID: 30684506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.